U.S. Markets open in 5 hrs 58 mins
  • S&P Futures

    3,925.50
    +21.75 (+0.56%)
     
  • Dow Futures

    31,586.00
    +165.00 (+0.53%)
     
  • Nasdaq Futures

    12,117.00
    +76.50 (+0.64%)
     
  • Russell 2000 Futures

    1,784.00
    +14.20 (+0.80%)
     
  • Crude Oil

    111.60
    +2.03 (+1.85%)
     
  • Gold

    1,828.80
    +4.00 (+0.22%)
     
  • Silver

    21.31
    +0.14 (+0.67%)
     
  • EUR/USD

    1.0594
    +0.0008 (+0.0742%)
     
  • 10-Yr Bond

    3.1940
    0.0000 (0.00%)
     
  • Vix

    26.91
    -0.32 (-1.18%)
     
  • GBP/USD

    1.2261
    -0.0009 (-0.0772%)
     
  • USD/JPY

    135.7530
    +0.3070 (+0.2267%)
     
  • BTC-USD

    20,885.28
    -487.31 (-2.28%)
     
  • CMC Crypto 200

    455.50
    -6.30 (-1.36%)
     
  • FTSE 100

    7,328.75
    +70.43 (+0.97%)
     
  • Nikkei 225

    27,049.47
    +178.17 (+0.66%)
     

Why Agenus Stock Is Crushing It Today

·1 min read
Why Agenus Stock Is Crushing It Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Shares of clinical-stage immunotherapy company Agenus (NASDAQ: AGEN) were up by a healthy 18% as of 1:09 p.m. ET on Wednesday. What appears to really be moving the stock, though, is a price target upgrade by financial firm H.C. Wainwright. In response to the impressive clinical progress of Agenus' anti-cancer checkpoint inhibitor platform, Wainwright raised its 12-month price target on the biotech's shares to $14 ahead of the opening bell this morning.